PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) said it will report its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before U.S. financial markets open.
The company announced that it will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss the results.
Investors may access the live and replay webcast through the investor relations section of the company’s website at https://ir.harmonybiosciences.com/.
Harmony Biosciences, headquartered in Plymouth Meeting, develops and commercializes therapies for patients with rare neurological diseases. The company was established in 2017 by Paragon Biosciences LLC.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.